Clinical Trials: A Phase I Efficacy and Safety Study of HPV16-specific Therapeutic DNA-vaccinia Vaccination in Combination With Topical Imiquimod, in Patients With HPV16+ High Grade Cervical Dysplasia (CIN3)

Share this article:

Sponsor and Collaborators

Johns Hopkins University

National Cancer Institute (NCI)

Contact

Clinical Trials Office, Sidney Kimmel Comprehensive Cancer Center

410-955-8804

jhcccro@jhmi.edu

Principal Investigator

Cornelia L. Trimble, MD Sidney Kimmel Comprehensive Cancer Center

ClinicalTrials.gov Identifier

NCT00788164

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Cervical Cancer Clinical Trials

Clinical Trial: Ixabepilone to Treat Cervical Cancer

Clinical trial focusing on Ixabepilone and cervical cancer. Ixabepilone to Treat Cervical Cancer

Clinical Trial: An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in ...

Clinical trial focusing on MRI guided brachytherapy. An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer (EMBRACE)

Clinical Trial: Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

Clinical trial focusing on mapatumumab, cisplatin, and radiotherapy. Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer